Laboratory Services News & Publications
Important Testing Notification
Please see important testing notification regarding potential for false-positive Norovirus with Gastrointestinal Infection Array (GIIA) Testing.
Testing Updates
March 5, 2024
New Test: Updates to Covid-19 IgG Semi-Quantitative and Qualitative Tests
Feb 27, 2024
Important Test Update: Cystatin C with estimated Glomerular Filtration Rate (GFR)
Feb 13, 2024
New Test: IgA with Reflex to IgG and IgM
Important Test Announcement: Revised susceptibility interpretive criteria for Pseudomonas aeruginosa and Enteric Gram Negative Rods
Nov 2023- New Test Announcement-Monocyte Type I and II Interferon Signature Quantitation by Flow Cytometry (T1A2MP). For more information, click here
New Reference Ranges
March 11. 2024
Changes in reference ranges for Plasma Amino Acids by LC-MS/MS
April 20, 2023
Changes in Chemistry methodology and reference ranges; Rheumatoid Factor (RA) testing returns in-house; Ceruloplasmin (XCERU) referred to ARUP for testing. For more information, click here.
April 10, 2023
White blood cell differential absolute values and percent immature granulocytes will begin reporting with normal reference ranges. For more information, click here.
Laboratory Services Newsletters
2024 Newsletters
2023 Newsletters
Sexually Transmitted Infection Testing Resources
Nationwide Children’s Laboratory Services provides resources for health care professionals, including a Sexually Transmitted Infections Practice Tool. Visit Clinical Tools for a complete list.
Included in the current STI Practice Tool are recommendations from the Centers for Disease Control and Prevention (CDC) regarding “opt-out” testing policies.
According to CDC recommendations, providers might consider opt-out chlamydia and gonorrhea screening (i.e., the patient is notified that testing will be performed unless the patient declines, regardless of reported sexual activity) for adolescent and young adult females during clinical encounters. Cost-effectiveness analyses indicate that opt-out chlamydia screening among adolescent and young adult females might substantially increase screening, be cost saving and identify infections among patients who do not disclose sexual behavior.
Nationwide Children’s has provided sample opt-out letters that providers may download and customize for patient/parent communication:
Patient Letter (Customizable)
Download:
Parent Letter (Customizable)
Download: